BioXcel BioXcel
Manufacturing · Connecticut, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
555 Long Wharf Dr Fl 12, New Haven, Conn...Phone Number
(203) 957-2487Website
www.bioxcel.comRevenue
<$5 MillionIndustry
About BioXcel BioXcel
BioXcel LLC is a biopharmaceutical company that leverages advanced technologies, particularly Artificial Intelligence, to develop transformative medicines across various therapeutic areas with significant unmet needs. Their proprietary AI platform, EvolverAI, accelerates drug discovery and development, exemplified by the rapid launch of IGALMI, a treatment for agitation associated with schizophrenia and bipolar disorders. The company aims to optimize research and development processes, reducing costs and timelines while enhancing productivity. BioXcel's target clients include patients and healthcare providers seeking innovative solutions in neuroscience and immuno-oncology.Explore more
BioXcel BioXcel Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to BioXcel BioXcel
Compare insights from companies similar to BioXcel BioXcel, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
BioXcel BioXcel
<$5M
11-50
Private
-
-
HS
Himani SharmaBioxcel Vice President, Corporate Strategy & Innovation (India)
BioXcel BioXcel Tech Stack
A closer look at the technologies used by BioXcel BioXcel
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding BioXcel BioXcel
Sign Up For FreeTo access detailed company insights
BioXcel LLC is a biopharmaceutical company that leverages advanced technologies, particularly Artificial Intelligence, to develop transformative medicines across various therapeutic areas with significant unmet needs. Their proprietary AI platform, EvolverAI, accelerates drug discovery and development, exemplified by the rapid launch of IGALMI, a t... Read More
